Health

High rates of Indigenous people in jail is a health crisis

The overincarceration of Indigenous people in Canada is a health crisis, causing more years of life to be lost than premature death from heart disease, injuries and cancer, argues a commentary in CMAJ (Canadian Medical Association ...

Cardiology

Heart failure deaths rising in younger adults

Death rates due to heart failure are now increasing, and this increase is most prominent among younger adults under 65, considered premature death, reports a new Northwestern Medicine study.

Cardiology

Burden of heart failure-related CVD mortality higher in blacks

(HealthDay)—The burden of heart failure-related cardiovascular disease (CVD) mortality is increased among young and middle-aged blacks, according to a research letter published in the May 14 issue of the Journal of the ...

Cardiology

Arsenic in drinking water may change heart structure

Drinking water that is contaminated with arsenic may lead to thickening of the heart's main pumping chamber in young adults, a structural change that increases the risk for future heart problems, according to new research ...

Cardiology

Sex drug 'effective' as heart failure treatment

A drug used to treat erectile dysfunction has been found by University of Manchester scientists to slow or even reverse the progression of heart failure in sheep.

Psychology & Psychiatry

Improving the well-being of heart-failure patients

Many patients with an implantable cardioverter defibrillator (ICD) are anxious of the shock delivered by the device to stop life-threatening ventricular arrhythmia or fibrillation. First, the electric shock in the chest can ...

Cardiology

Surgeon who transplanted baboon heart into baby dies

Dr. Leonard Bailey, who in 1984 transplanted a baboon heart into a tiny newborn dubbed "Baby Fae" in a pioneering operation that sparked both worldwide acclaim and condemnation, has died. He was 76.

Alzheimer's disease & dementia

No cure for Alzheimer's disease in my lifetime

Biogen recently announced that it was abandoning its late stage drug for Alzheimer's, aducanumab, causing investors to lose billions of dollars.

page 8 from 23